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Introduction 
GTP cyclohydrolase I (EC 3,5,4,16) is the first and 
rate-limiting enzyme for the biosynthesis of tetra-
hydrobiopterin in mammals (1). Tetrahydrobiopte-
rin has multiple physiological functions. It acts as 
an essential cofactor for three aromatic amino acid 
monooxygenases, i.e., phenylalanine, tyrosine, and 
tryptophan hydroxylases (2-4). These enzymes are 
essential for synthesizing hormones and neurotr-
ansmitters such as dopamine, noradrenaline, adre-
naline, and serotonin. It has also been shown that 
tetrahydrobiopterin acts as a cofactor for the gener-
ation of nitric oxide (NO) from arginine (5,6). 
GTP cyclohydrolase I cDNA was first isolated 
from a rat liver cDNA library (7). We had reported 
the isolation of three types of GTP cyclohydrolase 
I cDNA clones from human liver (8). The human 
three cDNAs were identical at their central and 5' 
regions but diverged at their 3' ends. We designated 
these three cDNAs as type 1, type 2, and type 3. Type 
I cDNA, which has the longest coding region, con-
sisting of 250 amino acids, corresponds to the cDNA 
reported from rat (7) and mouse (9). 
Very recently we found that the gene for GTP 
cyclohdrolase I is a causative gene for hereditary 
progressive dystonia with marked diurnal fluctua-
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tion (HPD), also dnown as DOPA responsive dys-
tonia (DRD) (10). This disease is inherited as an 
autosomal dominant trait with a low penetrance. We 
found that HPD/DRD patients had genetic defects 
in the GTP cyclohydrolase I gene only in one allele 
and that their GTP cyclohydrolase I activity in 
mononuclear blood cells was reduced to less than 
20% of that of normal individuals. If only one allele 
carries the mutant gene, the enzyme activity would 
be expected to be decreased to about half of the 
control value. We assumed that expression of GTP 
cyclohydrolase I in HPD/DRD patients would be 
lower than that in normal individuals. To elucidate 
the etiology of HPD/DRD in more detail, it is im-
portant to explore the mechanisms regulating the 
expression of the GTP cyclohydrolase I gene. 
On the other hand, there have been several re-
ports on tetrahydrobiopterin-dependent hyperphen-
ylalaninemia caused by a deficiency in GTP cy-
c1ohydrolase I (11-13). Hyperphenylalaninemia 
caused by GTP cyclohydrolase I deficiency shows 
more severe symptoms than that caused by a defect 
in phenylalanine hydroxylase, because a deficiency 
in GTP cyclohydrolase I impairs the biosynthesis 
of both catecholamines and serotonin due to the 
lack of tetrahydrobiopterin. The patients show se-
vere retardation of development, severe muscular 
hypotonia of the trunk and hypetronia of the ext-
remities, convulasins, and frequent episodes of hy-
perthermia without infections (11-13). 
Here we have reported genormic DNA structures 
for the human and mouse GTP cyclohydrolase I 
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genes and mutations in the GTP cyclohydrolase I 
gene found in patients with GTP cyclohydrolase I 
deficiency (14,15). 
Materials and Methods 
A mouse genmic library, constructed in A. Fixll 
phage vectors (Stratagene), was screened by use of 
a mouse GTP cyclohydrolase I cDNA clone (9) la-
beled with [a-32p]dCTP. Human genomic DNA li-
braries, constructed in Charon4A (donated bv Dr. 
Tom Maniatis: Har\"ard University) and in EMBL3 
(LIOI8; donated by the Japanese Cancer Research 
Resources Bank) were screened with a human GTP 
cyclohydrolase I cDNA clone (8) used as a probe. 
DNAs were isolated from the purified phage pla-
ques following standard protocols, and the frag-
ments of interest were subcloned into pBluescriptKS 
(Stratagene) or pUC 119 vectors for furthe structural 
analysis. 
Genomic DNA was extracted from primary skin 
fibroblasts. We amplicied exons for GTP cyclohy-
drolase I including splicing junctions using the PCR 
on genomic DNA. Primer sequences used for 
amlification of exons were as follws: exon 1,5'-GT-
ITAGCCGCAGACCTCGAAGCG-3' and 5'-GA-
GGCAACTCCGGAAACTTCCTG-3'; exon 2,5'-GT-
AACGCTCGCTTATGTTGACTGTC-3' and 5'-AC-
CTGAGATATCAGCAATTGGCAGC-3': exon 3,5' 
-AGATGTTTTCAAGGTAATACATTGTCG-3' 
and 5'-TAGATTCTCAGCAGATGAGGGCAG-3'; 
exon 4,5'-GTCCI I I I IGTTTTATGAGGAAGGC-
3' and 5'-GGTGATGCACTCTTATAATCTCAGC-
3'; exon 5,5'-GTGTCAGACTCTCAAACTGAGCTC 
-3' and 5'-TCACTTCTAGTGCACCATTATGACG 
-3'; enon 6,5'-ACCAAACCAGCAGCTGTCTAC-
TCC-3' and 5'-AATGCTACTGGCAGTACGATC-
GG-3'. PCR amplification and sequence analysis 
were performed as described previously (10). 
Results 
Using the cloned mouse and human cDNAs as 
a probe, we isolated genomic DNA clones for mouse 
and human GTP cyclohydrolase I. Structural ana-
lysis of these clones and PCR analyses revealed that 
the both mouse and human genes consist of a total 
of 6 exons (Fig. 1 ). We sequenced the exons and 
their splice sites.Each exon/intron boundary con-
formed perfectly to the GT/AG rule (16). 
The nucleotide sequences of the 5'-flanking re-
gion for the mouse and human genes were deter-
mined to about 600 bp upstream from the transc-
riptional starting site. No obvious TATA box was 
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Fig. 1. Structure of the mouse GTP cyclohydrolase I gene. 
The structure of the mouse GTP cyclohydrolase I gene is 
depicted at the top of the figure. The 6 exons are indica-
ted by closed boxes, and introns are represented by thin 
horizontal lines. Five isolated clones covering more than 30 
kb of the mouse GTP cyclohydrolase I gene are depicted 
below the structure of the gene. EcoRI restriction sites (E) 
are indicated by vertical bars. 
observed in the promoter region. In the mouse gene, 
an AT-rich putative projmoter motif (ATAAAAA) 
or a CCAA T box was present just upstr~am or 50 
bp upstream from the transcriptional startlr.!1g site, 
respectively, and an Hl-box(17), an IBP-Ib (18), 
anhd a GT-2B (19) binding consensus sequcTlce 
were found. The AT-rich putative promoter motif 
and CCAA T box found in the mouse gene vere 
conserved in the human GTP cyclohydrolase I gene 
A consensus sequence for the binding of GT-2B (19) 
was found in the human gene as well as in the 
mouse gene. The IBP-lb and HI-box consensus se-
quences found in the mouse gene were not present 
in the human gene, whereas a leader binding pro-
tein-I (LBP-l;20) binding sequence motif «AfT) 
CTGG; -475 to -479), a T-antigen binding motif 
(-272 to -277), a TGGCA box (-671 to -675), 
and as SPI consensus sequence (- 236 to - 245) 
were present in the human gene. 
To search for mutations in the coding region of 
the human GTP cyclohydrolase I gene, we ampli-
fied exons including splicing junctions from geno-
mic DNA by PCR. Amplified DNA fragments were 
directly sequenced with an automated DNA sequen-
cer. 
We examined two patients with GTP cyclohyd-
rolase I deficiency (Patient N.R. and Patient M.K) 
and normal individuals. Patients had missense 
mutations in both alleles. Patient N.R. had an A 
nucleotide instead of the G nucleotide found in 
normal subjects, and this mutation resulted in an 
amino acid substitution of methionine by isoleucine 
at position 211 (Met211Ile) (14). Patient M.K sho-
wed a transition from G to A, and the arginine re-
sidue was substitute with a histidine residue at po-
sition 184 (ArgI84His). Both patients were homo-
zygous in terms of the mutations, and no other 
mutations were, found in the coding region of their 
GTP cyclohydrolase I gene. These substiution affect 
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human MEKGPVRAPA Ela'RGARCSN GFPBRDPPRP GPSRPABKPP RPI!:AXSAQPA DGWKGERPRS 60 
rat M -----V--T- -----EL--- -A------SR P----G---- -A--AG---- 51 
DOUse M -----V--T- --S--BL--- -A-P----SR P----G---- -A--AG-H-- 51 
88 
human EEDNELNLPN LAAAYSSrLS SLGENPQRQG LLKTPWRAAS AMQFFTKGYQ ETrsDVLNDA 120 
rat 
---------- ---------R ----D----- ---------T ---------- 111 
mouse --E-QV---K ---------L ----D-- --- ---------T ---Y------ ---------- 111 
134 
human rFDEDHDEMV rvKDrDMFSM CEHHLVPlPYG XVIUGYLPNK QVLGLSKLAR rvErYSRRLQ 180 
rat 
---------- ---------- ---------- R--------- ---------- 171 
mouse ---------- ---------- ~--------- R--------- ---------- ---------- 171 
184 201 211 
human VQERLTKQrA VArTBALRPA GVGVVVEATH MCKVHRGVQK MNSXTVTS'l'M LGVFRBDPKT 240 
rat 
-------Q-- -----r---- 231 
mou.e 
-------Q-- -----r---- ---------- ---------- ---------- 231 
hciaan 
rat 
mouse 
REEFLTLrRS 250 
241 
:241 
Figure 2. Comparison of amino acid sequences of human (8), rat (7), and mouse (9) GTP cyclohydrolase I's. Amino acids 
identical with those of human GTP cyclohydrolase I are indicated by hyphens. Positions of aberrant GTP cyc1ohydrolase 
I residues found in patients with GTP cyc1hydrolase I deficiency (14,15) and in patiens with HPD/DRD (10) are emphasized 
by the larger letter with the position mumber at the top of the human sequence. 
highly conserved amino acid residues of GTP cy-
clohydrolase I (Fig. 2). 
Discussion 
Here we demonstrated that patients with GTP 
cyclohydrolase I deficiency were homozygous for a 
defect in the GTP cyclohydrolase I gene, whereas 
HPD/DRD patients were heterozygous. In HDP/ 
DRD patients, we had found three missense mu-
tations, Arg88Trp, Asp134Val, and Gly201Glu, and 
a two-base insertion that shifts the reading frame 
just after the translational starting methionine (10). 
We had expressed the mutated enzymes that had 
the Arg88Trp or Gly201Glu mutation in the E. coli 
expression system (10). Transfection with cDNA 
prepared from patients with GTP cyclohydrolase I 
deficiency as well as that from HPD/DRD ones 
failed to give the increase in the GTP cyclohydro-
lase I activity seen in the bacteria transfected with 
the wild-type cDNA, indicating that mutated enzy-
mes had practically no catalytic activity (10.15). 
These results indicate that there is no qualitative 
difference between the mutations in GTP cyclohy-
drolase I deficiency and those in HPD/DRD. Since 
GTP cyclohydrolase I deficiency is a recessive dis-
ease and both alleles of the gene are mutated as 
demonstrated by this paper, patients with GTP cy-
clohydrolase I dificiency have no detectable amount 
of the enzyme activity. 
On the other hand, autosomal dominant inheri-
tance with low penetrance is shown in HDP/DRD. 
Patients with HPD/DRD carry a mutated gene only 
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in one allele, and they have a little but substantial 
activity of GTP cyclohydrolase I (10). Therefore the 
difference in the level of the enzyme activity would 
explain the differing clinical presentation of these 
disorders, although both mutations of these disor-
ders reduced the activity of mutated proteins to zero. 
GTP cyclohydrolase I forms dihydroneopterin tri-
phosphate from GTP through a very complex me-
chanism (1), and the amino acid sequence of the 
enzyme is highly conserved among different species. 
Thus various single amino acid substitutions would 
be expected to result in a loss of the enzyme activity. 
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